Detalhe da pesquisa
1.
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Lancet
; 397(10269): 119-127, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422245
2.
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Lancet Infect Dis
; 23(8): 974-982, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127045
3.
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Lancet Infect Dis
; 23(8): 965-973, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127047